Xarelto Lawsuit Expert Interview

From EjWiki

Our attorneys have filed a mass tort lawsuit on behalf of sufferers who took the blood thinner Xarelto (rivaroxaban) and suffered critical bleeding events. Pharmaceutical companies, including the makers of Xarelto, have a duty to make sure that their drugs are reasonably protected for use - and failure to do so may be grounds for compensation. Our lawyers are functioning difficult to get those hurt by the drug the compensation they may be entitled to.

Although bleeding is really a widespread complication associated with anticoagulants, it has been alleged that Xarelto is far more dangerous than standard blood thinners simply because no antidote exists to reverse its blood-thinning effects. This implies that, within the event of an emergency, patients might be at risk for irreversible bleeding problems, including life-threatening internal and gastrointestinal hemorrhaging.

If you or even a loved one particular suffered a serious bleeding occasion following taking Xarelto, you might have legal recourse. For much more information, speak to us these days to possess your case reviewed, free of charge of charge.
Compensation Possibilities

xarelto-compensation-photoThe plaintiffs in these lawsuits are seeking compensation from Bayer and Janssen for past and future medical bills, lost wages, pain and suffering and, in situations of death, funeral costs. Additionally, they're in search of punitive damages, which are normally awarded to punish the defendant and deter other organizations from acting similarly.
Why Are Lawsuits Getting Filed?

Bayer and Johnson & Johnson’s Janssen Pharmaceuticals, Inc. are facing several Xarelto lawsuits alleging that the drug is harmful and defective. The plaintiffs claim that, unlike traditional anticoagulants (e.g. warfarin, Coumadin) whose blood-thinning effects can be reversed using vitamin K, there is no antidote available for Xarelto. Because of this, the lawsuits claim, doctors have no effective signifies of stopping Xarelto users from bleeding within the occasion of an emergency. Plaintiffs in the lawsuits allege severe and fatal injuries, like cerebral hemorrhaging and gastrointestinal bleeds, from use of the drug.

In addition to these risks, lawsuits against Bayer and Johnson & Johnson’s Janssen Pharmaceuticals are alleging:

The manufacturers of Xarelto Http://Xareltoupdate.Bitballoon.Com/ marketed the drug as a superior inside the field of anticoagulants despite studies finding higher rates of gastrointestinal (GI tract) bleeding and transfusions in Xarelto users than users of certain competitors.
The makers of the drug continue to market Xarelto as a safe anticoagulant option.
Doctors and healthcare staff were not properly made aware of methods to stabilize and treat a Xarelto user inside the event of a bleeding complication.
Users of Xarelto were not adequately warned of the health risks of suffering a fatal bleeding event.
Xarelto is linked to critical bleeding complications, excessive blood loss, intracranial hemorrhaging, eye bleeding (vitreous hemorrhage), stomach bleeding, gastrointestinal bleeding, wound infections from inhibited clotting, and lack of effectiveness in preventing dangerous clotting.

Visit this page for much more info on the alleged health risks of Xarelto.
Multidistrict Litigation Trial Dates Set

The attorneys within the Complex Litigation Group have filed lawsuits on behalf of injured clients. The claims will proceed through multidistrict litigation (MDL), which currently entails four trials, scheduled for Fall 2016, in which random groups of plaintiffs will be chosen to represent the group.